 SOUTH SAN FRANCISCO, Calif., Feb. 01, 2021 GLOBE NEWSWIRE -- Cytokinetics, Incorporated Nasdaq: CYTK today announced that on January 29, 2021 it granted stock options to purchase an aggregate of 13,500 shares of common stock to Cinzia Ellero, a new employee whose employment commenced in January 2021 as a material inducement to her employment. The grant was previously approved by the Compensation and Talent Committee of Cytokinetics Board of Directors under the companys Amended and Restated 2004 Equity Incentive Plan. 